Scopus BioPharma Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Scopus BioPharma Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2022.
  • Scopus BioPharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $2.02M.
  • Scopus BioPharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $242K, a 98.6% decline from 2021.
  • Scopus BioPharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $17.6M, a 303% increase from 2020.
  • Scopus BioPharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $4.35M, a 99.3% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $242K -$17.3M -98.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-14
2021 $17.6M +$13.2M +303% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-14
2020 $4.35M +$2.17M +99.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $2.18M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.